Xeris Biopharma Holdings, Inc.

Biotechnology • Healthcare • Chicago, IL, United States • XERS (NMS)

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday - The Motley Fool

The Motley Fool • Dec 31

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Business Wire • Jan 2

Xeris Biopharma (NASDAQ:XERS) Trading Down 6.8% - Time to Sell? - MarketBeat

MarketBeat • Jan 2

Is Xeris Biopharma on the Verge of a Breakthrough? - StocksToTrade

StocksToTrade • Jan 1

Xeris Biopharma: A Balanced Perspective Needed (Rating Downgrade) - Seeking Alpha

Seeking Alpha • Dec 18

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Xeris Biopharma Holdings, Inc. had layoffs?

No layoff events have been recorded for Xeris Biopharma Holdings, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Xeris Biopharma Holdings, Inc. have?

Xeris Biopharma Holdings, Inc. has approximately 394 employees.

What industry is Xeris Biopharma Holdings, Inc. in?

Xeris Biopharma Holdings, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Xeris Biopharma Holdings, Inc. a publicly traded company?

Yes, Xeris Biopharma Holdings, Inc. is publicly traded under the ticker symbol XERS on the NMS. The company has a market capitalization of approximately $1.20 billion.

Where is Xeris Biopharma Holdings, Inc. headquartered?

Xeris Biopharma Holdings, Inc. is headquartered in Chicago, IL, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.